Role of extracellular vesicles in nephrology. Prospective use in therapy of kidneys and urinary tract diseases

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Extracellular vesicles (EVs) represent heterogeneous population of the microparticles liberated by almost all live cages which are widely investigated recently in various biological and medical areas. They usually consist of two basic types (exosomes and microvesicles) and recently draw the increasing attention in quality mesenges of the cellular alarm system. Really, these vesicles can influence on cages-recipients, transferring and delivering difficult complexes of biomolecules (the lipids, proteins, coagulation factors, antigene, nucleinic acids), protected from enzymatic to degradation in environment. Importance EVs has been shown in pathophysiology several bodies, in particular, in kidneys where various types of cages нефрона allocate EVs which mediate their communication with underlaying cages urinogenous ways. By numerous researches it is established that EVs are involved in cellular communications during the regenerative and pathological processes occurring in a kidney. During the last years also it has been proved that vesicles play an important role in normal physiology of kidneys. Though many mechanisms EVs at illnesses are still studied insufficiently, in particular, in kidneys, opening of a role of additional mechanisms can help to throw light on the biological processes proceeding in kidneys. Eventually, extracellular vesicles, allocated with nephritic cages, collect in urine, becoming, thus, the big resource as markers of illnesses urinogenous a path and the perspective noninvasive diagnostic tool at nephritic illnesses. In the present review we discuss the latest data about a role EVs in pathophysiology of kidneys and their potential prospects in diagnostics and therapy of nephritic illness.

About the authors

Vladimir I. Vashchenko

S.M. Kirov Military Medical Academy

Author for correspondence.
Email: vladimir-vaschenko@yandex.ru

Dr. Biol. Sci., Senior Researcher, Centre of Blood and Tissues

Russian Federation, Saint Petersburg

Petr D. Shabanov

S.M. Kirov Military Medical Academy

Email: pdshabanov@mail.ru

Head, Department of Pharmacology

Russian Federation, Saint Petersburg

References

  1. Бельских А.Н., Галагудза М.М., Болота А.С., и др. Нановезикулярная терапия. Эволюция концепции, современное состояние и перспективы. Сообщение 1. Нановезикулярная терапия острого повреждения почек // Военно-медицинский журнал. – 2018. – Т. 339. – № 2. – С. 60–66. [Bel’skikh AN, Galagudza MM, Golota AS, et al. Nanovesicular therapy. Evolution of the conception, the current state and prospectives. Communication 1. Nanovesicular therapy of acute kidney injury. Voenn-Med J. 2018;339(2):60-66. (In Russ.)]
  2. Ващенко В.И., Вильянинов В.Н., Скрипай Л.А., Сороколетова Е.Ф. Везикуляция эритроцитов человека. Ее роль в донорских эритроцитсодержащих компонентах // Вестник Российской военно-медицинской академии. – 2020. – № 1. – С. 173-179. [Vashchenko VI, Vilyaninov VN, Skripay LA, Sorokoletova EF. Vesiculation red blood cells. Its role in the donor erythrocytes components. Bulletin of the Russian Military Medical Academy. 2020;(1):173-179. (In Russ.)]
  3. Игнатова М.С., Длин В.В. Наследственные заболевания почек, протекающие с гематурией // Российский вестник перинатологии и педиатрии. - 2014. – Т. 59. – № 3. – С. 82–90. [Ignatova MS, Dlin VV. Hereditary kidney diseases running with hematuria. Ros Vest Perinatol Pediatr. 2014;59(3):82-90. (In Russ.)]
  4. Кондратов К.А., Головкин А.С., Федоров А.В. Методы изучения субпопуляций внеклеточных везикул // Цитология. – 2018. – Т. 60. – № 7. – С. 487–497. [Kondratov KA, Golovkin AS, Fedorov AV. Methods for investigation of extracellular vesicle subpopulation. Tsitologia. 2018;60(7):487-497. (In Russ.)]. https://doi.org/10.31116/tsitol.2018.07.01.
  5. Кореньков Д.А., Овчинникова О.М., Сельков С.А., Соколов Д.И. Роль микрочастиц в межклеточной коммуникации // Цитология. – 2014. – Т. 56. – № 7. – С. 480–488. [Korenkov DA, Ovchinnikova OM, Selkov SA, Sokolov DI. Role of microparticles in intercellular communication. Tsitologia. 2014;56(7):480-488. (In Russ.)]
  6. Луста К.А. Бактериальные мембранные внеклеточные нановезикулы: строение, биогенез, функции, использование в биотехнологии и медицине (обзор) // Прикладная биохимия и микробиология. – 2015. – Т. 51. – № 5. – С. 443. [Lusta KA. Bacterial outer membrane nanovesicles: Structure, biogenesis, functions, and application in biotechnology and medicine (Review). Appled Biochem Microbiol. 2015;51(5):443. (In Russ.)]. https://doi.org/10.7868/S0555109915040091.
  7. Abdeen A, Sonoda H, El-Shawarby R, et al. Urinary excretion pattern of exosomal aquaporin-2 in rats that received gentamicin. Amer J Physiol Ren Physiol. 2014;307(11): F1227-F12237. https://doi.org/10.1152/ajprenal.00140.2014.
  8. Abdeen A, Sonoda H, Oshikawa S, et al. Acetazolamide enhances the release of urinary exosomal aquaporin-1. Nephrol Dial Transplant. 2016;31(10):1623-1632. https://doi.org/10.1093/ndt/gfw033.
  9. Abid Hussein MN, Nieuwland R, Hau CM, et al. Cell-derived microparticles contain caspase 3 in vitro and in vivo. J Thromb Haemost. 2005;3(5):888-896. https://doi.org/10.1111/j.1538-7836.2005.01240.x.
  10. Alvarez ML, Khosroheidari M, Ravi RK, Di Stefano JK. Comparison of protein, microRNA, and mRNA yields using different methods of urinary exosome isolation for the discovery of kidney disease biomarkers. Kidney Int. 2012;82(9): 1024-1032. https://doi.org/10.1038/ki.2012.256.
  11. Alvarez S, Suazo C, Boltansky A, et al. Urinary exosomes as a source of kidney dysfunction biomarker in renal transplantation. Transplant Proc. 2013;45(10):3719-3723. https://doi.org/10.1016/j.transproceed.2013.08.079.
  12. Andreola G, Rivoltini L, Castelli C, et al. Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. J Exp Med. 2002;195(10):1303-1316. https://doi.org/10.1084/jem.20011624.
  13. Angelotti ML, Ronconi E, Ballerini L, et al. Characterization of renal progenitors committed toward tubular lineage and their regenerative potential in renal tubular injury. Stem Cells. 2012;30(8):1714-1725. https://doi.org/10.1002/stem.1130.
  14. Arroyo JD, Chevillet JR, Kroh EM, et al. Argonaute 2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA. 2011;108(12):5003-5008. https://doi.org/10.1073/pnas.1019055108.
  15. Babiker AA, Nilsson B, Ronquist G, et al. Transfer of functional prostasomal CD59 of metastatic prostatic cancer cell origin protects cells against complement attack. Prostate. 2005;62(2):105-114. https://doi.org/10.1002/pros.20102.
  16. Babiker AA, Ronquist G, Nilsson B, Ekdahl KN. Overexpression of ecto-protein kinases in prostasomes of metastatic cell origin. Prostate. 2006;66(7):675-686. https://doi.org/10.1002/pros.20268.
  17. Baietti MF, Zhang Z, Mortier E, et al. Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat Cell Biol. 2012;14(7):677-685. https://doi.org/10.1038/ncb2502.
  18. Barile L, Vassalli G. Exosomes: therapy delivery tools and biomarkers of diseases. Pharmacol Ther. 2017;174:63-78. https://doi.org/10.1016/j.pharmthera.2017.02.020.
  19. Barutta F, Tricarico M, Corbelli A, et al. Urinary exosomal microRNAs in incipient diabetic nephropathy. PLoS ONE. 2013;8:e73798. https://doi.org/10.1371/journal.pone.0073798.
  20. Basile DP, Anderson MD, Sutton TA. Pathophysiology of acute kidney injury. Compr Physiol. 2012;2(2):1303-1353. https://doi.org/10.1002/cphy.c110041.
  21. Becker A, Thakur BK, Weiss JM, et al. Extracellular vesicles in cancer: cell-to-cell mediators of metastasis. Cancer Cell. 2016;30(6):836-848. https://doi.org/10.1016/j.ccell.2016.10.009.
  22. Beckham CJ, Olsen J, Yin PN, et al. Bladder cancer exosomes contain EDIL-3/Del1 and facilitate cancer progression. J Urol. 2014;192(2):583-592. https://doi.org/10.1016/j.juro.2014.02.035.
  23. Benito-Martin A, Ucero AC, Zubiri I, et al. Osteoprotegerin in exosome-like vesicles from human cultured tubular cells and urine. PLoS ONE. 2013;8(8):e72387. https://doi.org/10.1371/journal.pone.0072387.
  24. Bijnsdorp IV, Geldof AA, Lavaei M, et al. Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients. J Extracell Vesicles. 2013;2:22097. https://doi.org/10.3402/jev.v2i0.22097.
  25. Bitzer M, Ben-Dov IZ, Thum T. Microparticles and microRNAs of endothelial progenitor cells ameliorate acute kidney injury. Kidney Int. 2012;82(2):375-377. https://doi.org/10.1038/ki.2012.152.
  26. Bobrie A, Colombo M, Raposo G, Théry C. Exosome secretion: molecular mechanisms and roles in immune responses. Traffic. 2011;12:1659-1668. https://doi.org/10.1111/j.1600-0854.2011.01225.x.
  27. Bolukbasi MF, Mizrak A, Ozdener GB, et al. miR-1289 and «Zipcode»-like Sequence Enrich mRNAs in Microvesicles. Mol Ther Nucleic Acids. 2012;1(12):e10. https://doi.org/10.1038/mtna.2011.2.
  28. Borges FT, Melo SA, Özdemir BC, et al. TGF-b1-containing exosomes from injured epithelial cells activate fibroblasts to initiate tissue regenerative responses and fibrosis. J Am Soc Nephrol. 2013;24(3):385-392. https://doi.org/10.1681/ASN.2012101031.
  29. Bruno S, Bussolati B, Grange C, et al. Isolation and characterization of resident mesenchymal stem cells in human glomeruli. Stem Cells Dev. 2009;18(6):867-880. https://doi.org/10.1089/scd.2008.0320.
  30. Bruno S, Collino F, Deregibus MC, et al. Microvesicles derived from human bone marrow mesenchymal stem cells inhibit tumor growth. Stem Cells Dev. 2013;22(5): 758-771. https://doi.org/10.1089/scd.2012.0304.
  31. Bruno S, Collino F, Iavello A, Camussi G. Effects of mesenchymal stromal cell-derived extracellular vesicles on tumor growth. Front Immunol. 2014;5:382. https://doi.org/10.3389/fimmu.2014.00382.
  32. Bruno S, Grange C, Collino F, et al. Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury. PLoS ONE. 2012;7(3): e33115. https://doi.org/10.1371/journal.pone.0033115.
  33. Bruno S, Porta S, Bussolati B. Extracellular vesicles in renal tissue damage and regeneration. Eur J Pharmacol. 2016;790:83-91. https://doi.org/10.1016/j.ejphar. 2016.06.058.
  34. Bruschi M, Santucci L, Ravera S, et al. Human urinary exosome proteome unveils its aerobic respiratory ability. J Proteomics. 2016;136:25-34. https://doi.org/10.1016/j.jprot.2016.02.001.
  35. Bryzgunova OE, Zaripov MM, Skvortsova TE, et al. Comparative study of extracellular vesicles from the urine of healthy individuals and prostate cancer patients. PLoS ONE. 2016;11: e0157566. https://doi.org/10.1371/journal.pone.0157566.
  36. Budnik V, Ruiz-Cañada C, Wendler F. Extracellular vesicles round off communication in the nervous system. Nat Rev Neurosci. 2016;17(3):160-172. https://doi.org/10.1038/nrn.2015.29.
  37. Burger D, Viñas JL, Akbari S, et al. Human endothelial colony-forming cells protect against acute kidney injury: role of exosomes. Am J Pathol. 2015;185(8):2309-2323. https://doi.org/10.1016/j.ajpath.2015.04.010.
  38. Bussolati B, Bruno S, Grange C, et al. Isolation of renal progenitor cells from adult human kidney. Am J Pathol. 2005;166(2):545-555. https://doi.org/10.1016/S0002-9440(10)62276-6.
  39. Buzas EI, György B, Nagy G, et al. Emerging role of extracellular vesicles in inflammatory diseases. Nat Rev Rheumatol. 2014;10(6):356-364. https://doi.org/10.1038/nrrheum.2014.19.
  40. Cantaluppi V, Gatti S, Medica D, et al. Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia-reperfusion injury by microRNA-dependent reprogramming of resident renal cells. Kidney Int. 2012;82(4):412-427. https://doi.org/10.1038/ki.2012.105.
  41. Cantaluppi V, Medica D, Mannari C, et al. Endothelial progenitor cell-derived extracellular vesicles protect from complement-mediated mesangial injury in experimental anti-Thy1.1 glomerulonephritis. Nephrol Dial Transplant. 2015;30(3):410-422. https://doi.org/10.1093/ndt/gfu364.
  42. Cha DJ, Franklin JL, Dou Y, et al. KRAS-dependent sorting of miRNA to exosomes. Elife. 2015;4:e07197. https://doi.org/10.7554/eLife.07197.
  43. Chen CL, Lai YF, Tang P, et al. Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients. J Proteome Res. 2012;11(12): 5611-5629. https://doi.org/10.1021/pr3008732.
  44. Chiabotto G, Bruno S, Collino F, Camussi G. Mesenchymal stromal cells epithelial transition induced by renal tubular cells-derived extracellular vesicles. PLoS ONE. 2016;11:e0159163. https://doi.org/10.1371/journal.pone.0159163.
  45. Chiaruttini N, Redondo-Morata L, Colom A, et al. Relaxation of loaded ESCRT-III spiral springs drives membrane deformation. Cell. 2015;163(4):866-879. https://doi.org/10.1016/j.cell.2015.10.017.
  46. Choi HY, Moon SJ, Ratliff BB, et al. Microparticles from kidney-derived mesenchymal stem cells act as carriers of proangiogenic signals and contribute to recovery from acute kidney injury. PLoS ONE. 2014;9(2):e87853. https://doi.org/10.1371/journal.pone.0087853.
  47. Cocucci E, Racchetti G, Meldolesi J. Shedding microvesicles: artefacts no more. Trends Cell Biol. 2009;19(2): 43-51. https://doi.org/10.1186/s12882-016-0415-3.
  48. Collino F, Bruno S, Incarnato D, et al. AKI recovery induced by mesenchymal stromal cell-derived extracellular vesicles carrying microRNAs. J Am Soc Nephrol. 2015;26(10): 2349-2360. https://doi.org/10.1681/ASN.2014070710.
  49. Collino F, Deregibus MC, Bruno S, et al. Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PLoS ONE. 2010;5(7): e11803. https://doi.org/10.1371/journal.pone.0011803.
  50. Corcoran C, Rani S, O’Driscoll L. MiR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression: extracellular miRNAs as biomarkers for CRPC. Prostate. 2014;74(13):1320-1334. https://doi.org/10.1002/pros.22848.
  51. Coumans FA, Brisson AR, Buzar EI, et al. Methodological guidelines to study extracellular vesicles. Circ Res. 2017;120(10):1632-1648. https://doi.org/10.1161/CIRCRESAHA.117.309417.
  52. Costa-Silva B, Aiello NM, Ocean AJ, et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol. 2015;17(6):816-826. https://doi.org/10.1038/ncb3169.
  53. Crawford ED, Petrylak D, Sartor O. Navigating the evolving therapeutic landscape in advanced prostate cancer. Urol Oncol. 2017;35:S1-S13. https://doi.org/10.1016/j.urolonc.2017.01.020.
  54. Da Silva ML, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci. 2006;119(Pt 11):2204-2213. https://doi.org/10.1242/jcs.02932.
  55. Dear JW. Urinary exosomes join the fight against infection. J Am Soc Nephrol. 2014;25(9):1889-1891. https://doi.org/10.1681/ASN.2014020204.
  56. Del Boccio P, Raimondo F, Pieragostino D, et al. A hyphenated microLC-Q-TOF-MS platform for exosomal lipidomics investigations: application to RCC urinary exosomes. Electrophoresis. 2012;33(4):689-696. https://doi.org/10.1002/elps.201100375.
  57. Del Conde I, Shrimpton CN, Thiagarajan P, López JA. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood. 2005;106(5):1604-1611. https://doi.org/10.1182/blood-2004-03-1095.
  58. Delić D, Eisele C, Schmid R, et al. Urinary exosomal miRNA signature in type II diabetic nephropathy patients. PLoS ONE. 2016;11(3):e0150154. https://doi.org/10.1371/journal.pone.0150154.
  59. De Palma G, Sallustio F, Curci C, et al. The three-gene signature in urinary extracellular vesicles from patients with clear cell renal cell carcinoma. J Cancer. 2016b;7(14): 1960-1967. https://doi.org/10.7150/jca.16123.
  60. De Palma G, Sallustio F, Schena FP. Clinical application of human urinary extracellular vesicles in kidney and urologic diseases. Int J Mol Sci. 2016a;17(7):E1043. https://doi.org/10.3390/ijms17071043.
  61. Deregibus MC, Figliolini F, D’Antico S, et al. Charge-based precipitation of extracellular vesicles. Int J Mol Med. 2016;38(5):1359-1366. https://doi.org/10.3892/ijmm.2016.2759.
  62. De Vrij J, Maas SL, Kwappenberg KM, et al. Glioblastoma-derived extracellular vesicles modify the phenotype of monocytic cells. Int J Cancer. 2015;137(7):1630-1642. https://doi.org/10.1002/ijc.29521.
  63. Dignat-George F, Boulanger CM. The many faces of endothelial microparticles. Arterioscler Thromb Vasc Biol. 2011;31(1): 27-33. https://doi.org/10.1161/ATVBAHA.110.218123.
  64. Dijkstra S, Birker IL, Smit FP, et al. Prostate cancer biomarker profiles in urinary sediments and exosomes. J Urol. 2014;191(4):1132-1138. https://doi.org/10.1016/j.juro. 2013.11.001.
  65. Dimov I, Jankovic Velickovic L, Stefanovic V. Urinary exosomes. Scientific World Journal. 2009;9:1107-1118. https://doi.org/10.1100/tsw.2009.128.
  66. Dimuccio V, Ranghino A, Praticò Barbato L, et al. Urinary CD133+ extracellular vesicles are decreased in kidney transplanted patients with slow graft function and vascular damage. PLoS ONE. 2014;9(8):e104490. https://doi.org/10.1371/journal.pone.0104490.
  67. Drake RR, Kislinger T. The proteomics of prostate cancer exosomes. Expert Rev Proteomics. 2014;11(2):167-177. https://doi.org/10.1586/14789450.2014.890894.
  68. Eissa S, Matboli M, Aboushahba R, et al. Urinary exosomal microRNA panel unravels novel biomarkers for diagnosis of type 2 diabetic kidney disease. J Diabetes Complicat. 2016;30(8):1585-1592. https://doi.org/10.1016/j.jdiacomp.2016.07.012.
  69. El Andaloussi S, Lakhal S, Mäger I, Wood MJ. Exosomes for targeted siRNA delivery across biological barriers. Adv Drug Deliv Rev. 2013;65(3):391-397. https://doi.org/10.1016/j.addr.2012.08.008.
  70. Esteva-Font C, Guillén-Gómez E, Diaz JM, et al. Renal sodium transporters are increased in urinary exosomes of cyclosporine-treated kidney transplant patients. Am J Nephrol. 2014;39(6):528-535. https://doi.org/10.1159/000362905.
  71. Fais S, O’Driscoll L, Borras FE, et al. Evidence-based clinical use of nanoscale extracellular vesicles in nanomedicine. ACS Nano. 2016;10(4):3886-3899. https://doi.org/10.1021/acsnano.5b08015.
  72. Feigerlova E, Battaglia-Hsu SF, Hauet T, Gueant JL. Extracellular vesicles as immune mediators in response to kidney injury. Am J Physiol Renal Physiol. 2018;314(1): F9-F21. https://doi.org/10.1152/ajiprenal.00336. 2017.
  73. Finger EC, Giaccia AJ. Hypoxia, inflammation, and the tumor microenvironment in metastatic disease. Cancer Metastasis Rev. 2010;29(2):285-293. https://doi.org/10.1007/s10555-010-9224-5.
  74. Fonsato V, Collino F, Herrera MB, et al. Human liver stem cell-derived microvesicles inhibit hepatoma growth in SCID mice by delivering antitumor microRNAs. Stem Cells. 2012;30(9):1985-1998. https://doi.org/10.1002/stem.1161.
  75. Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev. 2013;93(1):137-188. https://doi.org/10.1152/physrev.00045.2011.
  76. Francois H, Chatziantoniou C. Renal fibrosis: Recent translational aspects. Matrix Biol. 2018;(68-69):318-332. https://doi.org/10.1016/j.matbio.2017.12.013.
  77. Gallo S, Gili M, Lombardo G, et al. Stem cell-derived, microRNA-carrying extracellular vesicles: a novel approach to interfering with mesangial cell collagen production in a hyperglycaemic setting. PLoS ONE. 2016;11(9):e0162417. https://doi.org/10.1371/journal.pone.0162417.
  78. Gámez-Valero A, Lozano-Ramos SI, Bancu I, et al. Urinary extracellular vesicles as source of biomarkers in kidney diseases. Front Immunol. 2015;6:6. https://doi.org/10.3389/fimmu.2015.00006.
  79. Gan X, Gould SJ. Identification of an inhibitory budding signal that blocks the release of HIV particles and exosome/microvesicle proteins. Mol Biol Cell. 2011;22(6):817-830. https://doi.org/10.1091/mbc.E10-07-0625.
  80. Gatti S, Bruno S, Deregibus MC, et al. Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrol Dial Transplant. 2011;26(5):1474-1483. https://doi.org/10.1093/ndt/gfr015.
  81. Gerlach JQ, Krüger A, Gallogly S, et al. Surface glycosylation profiles of urine extracellular vesicles. PLoS ONE. 2013;8(9): e74801. https://doi.org/10.1371/journal.pone. 0074801.
  82. Gildea JJ, Seaton JE, Victor KG, et al. Exosomal transfer from human renal proximal tubule cells to distal tubule and collecting duct cells. Clin Biochem. 2014;47(15):89-94. https://doi.org/10.1016/j.clinbiochem.2014.06.018.
  83. Gonzales PA, Pisitkun T, Hoffert JD, et al. Large-scale proteomics and phosphoproteomics of urinary exosomes. J Am Soc Nephrol. 2009;20(2):363-379. https://doi.org/10.1681/ASN.2008040406.
  84. Gould SJ, Raposo G. As we wait: coping with an imperfect nomenclature for extracellular vesicles. J Extracell Vesicles. 2013;2:20389. https://doi.org/10.3402/jev.zv2i0. 20389.
  85. Gracia T, Wang X, Su Y, et al. Urinary exosomes contain microRNAs capable of paracrine modulation of tubular transporters in kidney. Sci Rep. 2017;7:40601. https://doi.org/10.1038/srep40601.
  86. Grange C, Moggio A, Tapparo M, et al. Protective effect and localization by optical imaging of human renal CD133+ progenitor cells in an acute kidney injury model. Physiol Rep. 2014;2(5): e12009. https://doi.org/10.14814/phy2.12009.
  87. Grange C, Tapparo M, Collino F, et al. Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. Cancer Res. 2011;71(15):5346-5356. https://doi.org/10.1158/0008-5472.CAN-11-0241.
  88. Grange C, Tapparo M, Tritta S, et al. Role of HLA-G and extracellular vesicles in renal cancer stem cell-induced inhibition of dendritic cell differentiation. BMC Cancer. 2015;15:1009. https://doi.org/10.1186/s12885-015-2025-z.
  89. Greco KA, Franzen CA, Foreman KE, et al. PLK-1 silencing in bladder cancer by siRNA delivered with exosomes. Urology. 2016;91:241.e1-7. https://doi.org/10.1016/j.urology.2016.01.028.
  90. Greening DW, Xu R, Ji H, et al. A protocol for exosome isolation and characterization: evaluation of ultracentrifugation, density-gradient separation, and immunoaffinity capture methods. Methods Mol Biol. 2015;1295:179-209. https://doi.org/10.1007/978-1-4939-2550-6_15.
  91. Gutwein P, Schramme A, Abdel-Bakky MS, et al. ADAM10 is expressed in human podocytes and found in urinary vesicles of patients with glomerular kidney diseases. J Biomed Sci. 2010;17(1):3. https://doi.org/10.1186/1423-0127-17-3.
  92. György B, Szabó TG, Pásztói M, et al. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci. 2011;68(16):2667-2688. https://doi.org/10.1007/s00018-011-0689-3.
  93. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646-674. https://doi.org/10.1016/j.cell.2011.02.013.
  94. Hara M, Yanagihara T, Hirayama Y, et al. Podocyte membrane vesicles in urine originate from tip vesiculation of podocyte microvilli. Hum Pathol. 2010;41(9):1265-1275. https://doi.org/10.1016/j.humpath.2010.02.004.
  95. Helmke A, von Vietinghoff S. Extracellular vesicles as mediators of vascular inflammation in kidney disease. World J Nephrol. 2016;5(2):125-138. https://doi.org/10.5527/wjn.v5.i2.125.
  96. Herrera MB, Bussolati B, Bruno S, et al. Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney Int. 2007;72(4): 430-441. https://doi.org/10.1038/sj.ki.5002334.
  97. Herrera Sanchez MB, Bruno S, Grange C, et al. Human liver stem cells and derived extracellular vesicles improve recovery in a murine model of acute kidney injury. Stem Cell Res Ther. 2014;5:124. https://doi.org/10.1186/scrt514.
  98. Hessvik NP, Phuyal S, Brech A, et al. Profiling of microRNAs in exosomes released from PC-3 prostate cancer cells. Biochim Biophys Acta. 2012;1819(11-12):1154-1163. https://doi.org/10.1016/j.bbagrm.2012.08.016.
  99. Hiemstra TF, Charles PD, Gracia T, et al. Human urinary exosomes as innate immune effectors. J Am Soc Nephrol. 2014;25(9):2017-2027. https://doi.org/10.1681/ASN. 2013101066.
  100. Higgins GC, Coughlan MT. Mitochondrial dysfunction and mitophagy: the beginning and end to diabetic nephropathy? Br J Pharmacol. 2014;171(8):1917-1942. https://doi.org/10.1111/bph.12503.
  101. Hogan MC, Bakeberg JL, Gainullin VG, et al. Identification of biomarkers for PKD1 using urinary exosomes. J Am Soc Nephrol. 2015;26(7):1661-1670. https://doi.org/10.1681/ASN.2014040354.
  102. Hogan MC, Johnson KL, Zenka RM, et al. Subfractionation, characterization, and in-depth proteomic analysis of glomerular membrane vesicles in human urine. Kidney Int. 2014;85(5):1225-1237. https://doi.org/10.1038/ki.2013.422.
  103. Hogan MC, Manganelli L, Woollard JR, et al. Characterization of PKD protein-positive exosome-like vesicles. J Am Soc Nephrol. 2009;20(2):278-288. https://doi.org/10.1681/ASN.2008060564.
  104. Hoshino A, Costa-Silva B, Shen TL, et al. Tumour exosome integrins determine organotropic metastasis. Nature. 2015;527(7578):329-335. https://doi.org/10.1038/nature15756.
  105. Hu S, Lie D, Tan X, et al. [Research progress in autosomal dominant polycystic kidney disease. (In Chinese)]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2019;44(10): 1179-1187. https://doi.org/10.11817/j.issn.1672-7347. 2019.180110.
  106. Huang X, Liang M, Dittmar R, Wang L. Extracellular microRNAs in urologic malignancies: chances and challenges. Int J Mol Sci. 2013;14(7):14785-14799. https://doi.org/10.3390/ijms140714785.
  107. Huber V, Fais S, Iero M, et al. Human colorectal cancer cells induce T-cell death through release of proapoptotic microvesicles: role in immune escape. Gastroenterology. 2005;128(7):1796-1804. https://doi.org/10.1053/j.gastro.2005.03.045.
  108. Hugel B, Martínez MC, Kunzelmann C, Freyssinet JM. Membrane microparticles: two sides of the coin. Physiology. 2005;20:22-27. https://doi.org/10.1152/physiol.00029.2004.
  109. Iavello A, Frech VS, Gai C, et al. Role of Alix in miRNA packaging during extracellular vesicle biogenesis. Int J Mol Med. 2016;37(4):958-966. https://doi.org/10.3892/ijmm.2016.2488.
  110. Ichii O, Otsuka-Kanazawa S, Horino T, et al. Decreased miR-26a expression correlates with the progression of podocyte injury in autoimmune glomerulonephritis. PLoS ONE. 2014;9:e110383. https://doi.org/10.1371/journal.pone.0110383.
  111. Iero M, Valenti R, Huber V, et al. Tumour-released exosomes and their implications in cancer immunity. Cell Death Differ. 2008;15(1):80-88. https://doi.org/10.1038/sj.cdd.4402237.
  112. Janowska-Wieczorek A, Wysoczynski M, Kijowski J, et al. Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int J Cancer. 2005;113(5):752-760. https://doi.org/10.1002/ijc.20657.
  113. Jella KK, Yu L, Yue Q, et al. Exosomal GAPDH from proximal tubule cells regulate ENaC activity. PLoS ONE. 2016;11(11):e0165763. https://doi.org/10.1371/journal.pone.0165763.
  114. Jia Y, Guan M, Zheng Z, et al. miRNAs in urine extracellular vesicles as predictors of early-stage diabetic nephropathy. J Diabetes Res. 2016;2016:7932765. https://doi.org/10.1155/2016/7932765.
  115. Jiang ZZ, Liu YM, Niu X, et al. Exosomes secreted by human urine-derived stem cells could prevent kidney complications from type I diabetes in rats. Stem Cell Res Ther. 2016;7:24. https://doi.org/10.1186/s13287-016-0287-2.
  116. Joo KW, Lee JW, Jang HR, et al. Reduced urinary excretion of thiazide sensitive NaCl cotransporter in Gitelman syndrome: Preliminary data. Am J Kidney Dis. 2007;50(5):765-773. https://doi.org/10.1053/j.ajkd.2007.07.022.
  117. Junker K, Heinzelmann J, Beckman C, et al. Extracellular vesicles and their role in urologic malignancies. Eur Urol. 2016;70(2):323-331. https://doi.org/10.1016/j.eururo. 2016.02.046.
  118. Kalani A, Mohan A, Godbole MM, et al. Wilm’s tumor-1 protein levels in urinary exosomes from diabetic patients with or without proteinuria. PLoS ONE. 2013;8(3):e60177. https://doi.org/10.1371/journal.pone.0060177.
  119. Kanazawa T, Ichii O, Otsuka S, et al. Hepatocyte nuclear factor 4 alpha is associated with mesenchymal-epithelial transition in developing kidneys of C57BL/6 mice. J Vet Med Sci. 2011;73(5):601-607. https://doi.org/10.1292/jvms.10-0493.
  120. Katsuda T, Kosaka N, Takeshita F, Ochiya T. The therapeutic potential of mesenchymal stem cell-derived extracellular vesicles. Proteomics. 2013;13(10-11):1637-1653. https://doi.org/10.1002/pmic.201200373.
  121. Keller S, Rupp C, Stoeck A, et al. CD24 is a marker of exosomes secreted into urine and amniotic fluid. Kidney Int. 2007;72(9):1095-1102. https://doi.org/10.1038/sj.ki.5002486.
  122. Witwer KW, Théry C. Extracellular vesicles or exosomes? On primacy, precision, and popularity influencing a choice of nomenclature. J Extracellular Vesicles. 2019;8(1):1648167. https://doi.org/10.1080/20013078.2019.1648167.
  123. Kesimer M, Scull M, Brighton B, et al. Characterization of exosome-like vesicles released from human tracheobronchial ciliated epithelium: a possible role in innate defense. FASEB J. 2009;23(6):1858-1868. https://doi.org/10.1096/fj.08-119131.
  124. Khurana R, Ranches G, Schafferer S, et al. Identification of urinary exosomal noncoding RNAs as novel biomarkers in chronic kidney disease. RNA. 2017;23(2):142-152. https://doi.org/10.1261/rna.058834.116.
  125. Kim CW, Lee HM, Lee TH, et al. Extracellular membrane vesicles from tumor cells promote angiogenesis via sphingomyelin. Cancer Res. 2002;62(21):6312-6317.
  126. King HW, Michael MZ, Gleadle JM. Hypoxic enhancement of exosome release by breast cancer cells. BMC Cancer. 2012;12:421. https://doi.org/10.1186/1471-2407-12-421.
  127. Kleinjan A, Boing AN, Sturk A, Nieuwland R. Microparticles in vascular disorders: how tissue factor-exposing vesicles contribute to pathology and physiology. Thromb Res. 2012;130(Suppl.1):S71-S73. https://doi.org/10.1016/j.thromres.2012.08.281.
  128. Knepper MA, Pisitkun T. Exosomes in urine: who would have thought? Kidney Int. 2007;72(9):1043-1045. https://doi.org/10.1038/sj.ki.5002510.
  129. Kohlhapp FJ, Mitra AK, Lengyel E, Peter ME. MicroRNAs as mediators and communicators between cancer cells and the tumor microenvironment. Oncogene. 2015;34(48):5857-5868. https://doi.org/10.1038/onc. 2015.89.
  130. Koppers-Lalic D, Hackenberg M, Bijnsdorp IV, et al. Nontemplated nucleotide additions distinguish the small RNA composition in cells from exosomes. Cell Rep. 2014;8(6):1649-1658. https://doi.org/10.1016/j.celrep.2014.08.027.
  131. Kwon SH. Extracellular vesicles in renal physiology and clinical applications for renal disease. Korean J Intern Med. 2019;34(3):470-479. https://doi.org/10.3904/kjim. 2019.108.
  132. Lai RC, Yeo RW, Lim SK. Mesenchymal stem cell exosomes. Semin Cell Dev Biol. 2015;40:82-88. https://doi.org/10.1016/j.semcdb.2015.03.001.
  133. Lange C, Tögel F, Ittrich H, et al. Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats. Kidney Int. 2005;68(4):1613-1617. https://doi.org/10.1111/j.1523-1755.2005.00573.x.
  134. Lee IH, Kai H, Carlson LA, et al. Negative membrane curvature catalyzes nucleation of endosomal sorting complex required for transport (ESCRT)-III assembly. Proc Natl Acad Sci U S A. 2015;112(52):15892-15897. https://doi.org/10.1073/pnas.1518765113.
  135. Lee Y, El Andaloussi S, Wood MJ. Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy. Hum Mol Genet. 2012;21(R1): R125-R134. https://doi.org/10.1093/hmg/dds317.
  136. Lin SY, Chang CH, Wu HC, et al. Proteome profiling of urinary exosomes identifies alpha 1-antitrypsin and H2B1K as diagnostic and prognostic biomarkers for urothelial carcinoma. Sci Rep. 2016;6:34446. https://doi.org/10.1038/srep34446.
  137. Lindenbach BD. Virion assembly and release. Curr Top Microbiol Immunol. 2013;369:199-218. https://doi.org/10.1007/978-3-642-27340-7_8.
  138. Lindoso RS, Collino F, Camussi G. Extracellular vesicles derived from renal cancer stem cells induce a pro-tumorigenic phenotype in mesenchymal stromal cells. Oncotarget. 2015;6(10):7959-7969. https://doi.org/10.18632/oncotarget.3503.
  139. Linxweiler J, Junker K. Extracellular vesicles in urological malignancies: an update. Nat Rev Urol. 2020;17(1):11-27. https://doi.org/10.1038/s41585-019-0261-8.
  140. Llorente A, Skotland T, Sylvänne T, et al. Molecular lipidomics of exosomes released by PC-3 prostate cancer cells. Biochim Biophys Acta. 2013;1831(7):1302-1309. https://doi.org/10.1016/j.bbalip.2013.04.011.
  141. Lombardo G, Dentelli P, Togliatto G, et al. Activated Stat5 trafficking via endothelial cell-derived extracellular vesicles controls IL-3 pro-angiogenic paracrine action. Sci Rep. 2016;6:25689. https://doi.org/10.1038/srep25689.
  142. Lopatina T, Gai C, Deregibus MC, et al. Cross talk between cancer and mesenchymal stem cells through extracellular vesicles carrying nucleic acids. Front Oncol. 2016;6:125. https://doi.org/10.3389/fonc.2016.00125.
  143. Lösche W, Scholz T, Temmler U, et al. Platelet-derived microvesicles transfer tissue factor to monocytes but not to neutrophils. Platelets. 2004;15(2):109-115. https://doi.org/10.1080/09537100310001649885.
  144. Lu Q, Zhang J, Allison R, et al. Identification of extracellular delta-catenin accumulation for prostate cancer detection. Prostate. 2009;69(4):411-418. https://doi.org/10.1002/pros.20902.
  145. Luan X, Sansanaphongpricha K, Myers I, et al. Engineering exosomes as refined biological nanoplatforms for drug delivery. Acta Pharmacol Sin. 2017;38(6):754-763. https://doi.org/10.1038/aps.2017.12.
  146. Lv LL, Cao YH, Ni HF, et al. MicroRNA-29c in urinary exosome/microvesicle as a biomarker of renal fibrosis. Am J Physiol Renal Physiol. 2013;305(8): F1220-F1227. https://doi.org/10.1152/ajprenal.00148.2013.
  147. Lv LL, Cao YH, Pan MM, et al. CD2AP mRNA in urinary exosome as biomarker of kidney disease. Clin Chim Acta. 2014;428:26-31. https://doi.org/10.1016/j.cca.2013.10.003.
  148. Lytvyn Y, Xiao F, Kennedy CR, et al. Assessment of urinary microparticles in normotensive patients with type 1 diabetes. Diabetologia. 2017;60(3):581-584. https://doi.org/10.1007/s00125-016-4190-2.
  149. Maas SL, Breakefield XO, Weaver AM. Extracellular vesicles: unique intercellular delivery vehicles. Trends Cell Biol. 2017;27(3):172-188. https://doi.org/10.1016/j.tcb. 2016.11.003.
  150. Machtinger R, Laurent LC, Baccarelli AA. Extracellular vesicles: roles in gamete maturation, fertilization and embryo implantation. Hum Reprod Update. 2016;22(2):182-193. https://doi.org/10.1093/humupd/dmv055.
  151. Maji S, Matsuda A, Yan IK, et al. Extracellular vesicles in liver diseases. Am J Physiol Gastrointest Liver Physiol. 2017;312(3):G194-G200. https://doi.org/10.1152/ajpgi.00216.2016.
  152. Masyuk AI, Huang BQ, Ward CJ, et al. Biliary exosomes influence cholangiocyte regulatory mechanisms and proliferation through interaction with primary cilia. Am J Physiol Gastrointest Liver Physiol. 2010;299(4):G990-G999. https://doi.org/10.1152/ajpgi.00093.2010.
  153. Mathivanan S, Ji H, Simpson RJ. Exosomes: extracellular organelles important in intercellular communication. J Proteomics. 2010;73(10):1907-1920. https://doi.org/10.1016/j.jprot.2010.06.006.
  154. McCullough J, Clippinger AK, Talledge N, et al. Structure and membrane remodeling activity of ESCRT-III helical polymers. Science. 2015;350(6267):1548-1551. https://doi.org/10.1126/science.aad8305.
  155. McKiernan J, Donovan MJ, O’Neill V, et al. Novel urine exosome gene expression assay to predict high-grade prostate cancer at initial biopsy. JAMA Oncol. 2016;2(7):882-889. https://doi.org/10.1001/jamaoncol.2016.0097.
  156. Medeiros T, Myette RL, Almeida JR, et al. Extracellular vesicles: cell-derived biomarkers of glomerular and tubular injury. Cell Physiol Biochem. 2020;54(1):88-109. https://doi.org/10.33594/000000207.
  157. Mendolesi J. Extracellular vesicles, news about their role in immune cells: physiology, pathology and diseases. Clin Exp Immunol. 2019;196(3):318-327. https://doi.org/10.1111/cei.13274.
  158. Miranda KC, Bond DT, McKee M, et al. Nucleic acids within urinary exosomes/microvesicles are potential biomarkers for renal disease. Kidney Int. 2010;78(2):191-199. https://doi.org/10.1038/ki.2010.106.
  159. Mitchell PJ, Welton J, Staffurth J, et al. Can urinary exosomes act as treatment response markers in prostate cancer? J Transl Med. 2009;7:4. https://doi.org/10.1186/1479-5876-7-4.
  160. Mohan A, Singh RS, Kumari M, et al. Urinary exosomal microRNA-451-5p is a potential early biomarker of diabetic nephropathy in rats. PLoS ONE. 2016;11:e0154055. https://doi.org/10.1371/journal.pone.0154055.
  161. Montecalvo A, Larregina AT, Shufesky WJ, et al. Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood. 2012;119(3): 756-766. https://doi.org/10.1182/blood-2011-02-338004.
  162. Moon PG, Lee JE, You S, et al. Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy. Proteomics. 2011;11(12):2459-2475. https://doi.org/10.1002/pmic. 201000443.
  163. Mostefai HA, Meziani F, Mastronardi ML, et al. Circulating microparticles from patients with septic shock exert protective role in vascular function. Am J Respir Crit Care Med. 2008;178(11):1148-1155. https://doi.org/10.1164/rccm.200712-1835OC.
  164. Motamedinia P, Scott AN, Bate KL, et al. Urine exosomes for non-invasive assessment of gene expression and mutations of prostate cancer. PLoS ONE. 2016;11: e0154507. https://doi.org/10.1371/journal.pone.0154507.
  165. Mulcahy LA, Pink RC, Carter DR. Routes and mechanisms of extracellular vesicle uptake. J Extracell Vesicles. 2014;3:24641. https://doi.org/10.3402/jev.v3.24641.
  166. Muralidharan-Chari V, Clancy J, Plou C, et al. ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles. Curr Biol. 2009;19(22):1875-1885. https://doi.org/10.1016/j.cub.2009.09.059.
  167. Musante L, Saraswat M, Duriez E, et al. Biochemical and physical characterisation of urinary nanovesicles following CHAPS treatment. PLoS ONE. 2012;7(7):e37279. https://doi.org/10.1371/journal.pone.0037279.
  168. Nabhan JF, Hu R, Oh RS, et al. Formation and release of arrestin domain-containing protein 1-mediated microvesicles (ARMMs) at plasma membrane by recruitment of TSG101 protein. Proc Natl Acad Sci USA. 2012;109(11):4146-4151. https://doi.org/10.1073/pnas. 1200448109.
  169. Navar LG, Harrison-Bernard LM, Nishiyama A, Kobori H. Regulation of intrarenal angiotensin II in hypertension. Hypertension. 2002;39:316-322. https://doi.org/10.1161/hy0202.103821.
  170. Nawaz M, Camussi G, Valadi H, et al. The emerging role of extracellular vesicles as biomarkers for urogenital cancers. Nat Rev Urol. 2014;11(12):688-701. https://doi.org/10.1038/nrurol.2014.301.
  171. Nilsson J, Skog J, Nordstrand A, et al. Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer. Br J Cancer. 2009;100(10): 1603-1607. https://doi.org/10.1038/sj.bjc.6605058.
  172. Njock MS, Cheng HS, Dang LT, et al. Endothelial cells suppress monocyte activation through secretion of extracellular vesicles containing antiinflammatory microRNAs. Blood. 2015;125(20):3202-3212. https://doi.org/10.1182/blood-2014-11-611046.
  173. Noltet Hoen EN, Buschow SI, Anderton SM, et al. Activated T cells recruit exosomes secreted by dendritic cells via LFA-1. Blood. 2009;113(9):1977-1981. https://doi.org/10.1182/blood-2008-08-174094.
  174. Nyalwidhe JO, Betesh L, Powers TW, et al. Increased bisecting N-acetylglucosamine and decreased branched chain glycans of N-linked glycoproteins in expressed prostatic secretions associated with prostate cancer progression. Proteomics Clin Appl. 2013;7(9-11):677-689. https://doi.org/10.1002/prca.201200134.
  175. Okada H. A new look at tubulointerstitial communication with exosomes. J Am Soc Nephrol. 2013;24(3):330-332. https://doi.org/10.1681/asn.2013010052.
  176. Oosthuyzen W, Scullion KM, Ivy JR, et al. Vasopressin regulates extracellular vesicle uptake by kidney collecting duct cells. J Am Soc Nephrol. 2016;27(11):3345-3355. https://doi.org/10.1681/ASN.2015050568.
  177. Oshikawa S, Sonoda H, Ikeda M. Aquaporins in urinary extracellular vesicles (exosomes). Int J Mol Sci. 2016;17(6):957. https://doi.org/10.3390/ijms17060957.
  178. Ostrowski M, Carmo NB, Krumeich S, et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol. 2010;12(1):19-30. https://doi.org/10.1038/ncb2000.
  179. Pang P, Abbott M, Chang SL, et al. Human vascular progenitor cells derived from renal arteries are endothelial-like and assist in the repair of injured renal capillary networks. Kidney Int. 2017;91(1):129-143. https://doi.org/10.1016/j.kint.2016.07.037.
  180. Panich T, Chancharoenthana W, Somparn P, et al. Urinary exosomal activating transcriptional factor 3 as the early diagnostic biomarker for sepsis-induced acute kidney injury. BMC Nephrol. 2017;18(1):10. https://doi.org/10.1186/s12882-016-0415-3.
  181. Park JE, Tan HS, Datta A, et al. Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes. Mol Cell Proteomics. 2010;9(6):1085-1099. https://doi.org/10.1074/mcp.M900381-MCP200.
  182. Parolini I, Federici C, Raggi C, et al. Microenvironmental pH is a key factor for exosome traffic in tumor cells. J Biol Chem. 2009;284(49):34211-34222. https://doi.org/10.1074/jbc.M109.041152.
  183. Peake PW, Pianta TJ, Succar L, et al. A comparison of the ability of levels of urinary biomarker proteins and exosomal mRNA to predict outcomes after renal transplantation. PLoS ONE. 2014;9(2):e98644. https://doi.org/10.1371/journal.pone.0098644.
  184. Peinado H, Aleckovic M, Lavotshkin S, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med. 2012;18(6):883-891. https://doi.org/10.1038/nm.2753.
  185. Perez A, Loizaga A, Arceo R, et al. A pilot study on the potential of RNA-associated to urinary vesicles as a suitable non-invasive source for diagnostic purposes in bladder cancer. Cancers. 2014;6(1):179-192. https://doi.org/10.3390/cancers6010179.
  186. Perez-Hernandez J, Forner MJ, Pinto C, et al. Increased urinary exosomal micrornas in patients with systemic lupus erythematosus. PLoS ONE. 2015;10(9):e0138618. https://doi.org/10.1371/journal.pone.0138618.
  187. Pisitkun T, Shen RF, Knepper MA. Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci USA. 2004;101(36):13368-13373. https://doi.org/10.1073/pnas.0403453101.
  188. Pocsfalvi G, Raj DA, Fiume I, et al. Urinary extracellular vesicles as reservoirs of altered proteins during the pathogenesis of polycystic kidney disease. Proteomics Clin Appl. 2015;9(5-6):552-567. https://doi.org/10.1002/prca.201400199.
  189. Pomato MA, Gai C, Bussolati B, Camussi G. Extracellular vesicles in renal pathophysiology. Front Mol Biosci. 2017;4:37. https://doi.org/10.3389/fmolb.2017.00037.
  190. Prado N, Marazuela EG, Segura E, et al. Exosomes from bronchoalveolar fluid of tolerized mice prevent allergic reaction. J Immunol. 2008;181(2):1519-1525. https://doi.org/10.4049/jimmunol.181.2.1519.
  191. Principe S, Jones EE, Kim Y, et al. In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. Proteomics. 2013;13(10-11):1667-1671. https://doi.org/10.1002/pmic.201200561.
  192. Prunotto M, Farina A, Lane L, et al. Proteomic analysis of podocyte exosome-enriched fraction from normal human urine. J Proteomics. 2013;82:193-229. https://doi.org/10.1016/j.jprot.2013.01.012.
  193. Quek C, Hill AF. The role of extracellular vesicles in neurodegenerative diseases. Biochem Biophys Res Commun. 2017;483(4):1178-1186. https://doi.org/10.1016/j.bbrc.2016.09.090.
  194. Raiborg C, Stenmark H. The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins. Nature. 2009;458(7237):445-452. https://doi.org/10.1038/nature07961.
  195. Raimondo F, Morosi L, Corbetta S, et al. Differential protein profiling of renal cell carcinoma urinary exosomes. Mol Biosyst. 2013;9(6):1220-1233. https://doi.org/10.1039/c3mb25582d.
  196. Ramachandra Rao SP, Matthias MA, Kokoy-Mondragon C, et al. Correction: Proteomic analysis of urine exosomes reveals renal tubule response to leptospiral colonization in experimentally infected rats. PLoS Negl Trop Dis. 2015;9(3):e0003640. https://doi.org/10.1371/journal.pntd.0003640.
  197. Ranghino A, Bruno S, Bussolati B, et al. The effects of glomerular and tubular renal progenitors and derived extracellular vesicles on recovery from acute kidney injury. Stem Cell Res Ther. 2017;8(1):24. https://doi.org/10.1186/s13287-017-0478-5.
  198. Ranghino A, Cantaluppi V, Grange C, et al. Endothelial progenitor cell-derived microvesicles improve neovascularization in a murine model of hindlimb ischemia. Int J Immunopathol Pharmacol. 2012;25(1):75-85 https://doi.org/10.1177/039463201202500110.
  199. Ranghino A, Dimuccio V, Papadimitriou E, Bussolati B. Extracellular vesicles in the urine: markers and mediators of tissue damage and regeneration. Clin Kidney J. 2015;8(1):23-30. https://doi.org/10.1093/ckj/sfu136.
  200. Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013;200(4): 373-383. https://doi.org/10.1083/jcb.201211138.
  201. Ratajczak MZ, Kucia M, Jadczyk T, et al. Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies? Leukemia. 2012;26(6):1166-1173. https://doi.org/10.1038/leu.2011.389.
  202. Ricci Z, Ronco C. Pathogenesis of acute kidney injury during sepsis. Curr Drug Targets. 2009;10(12):1179-1183. https://doi.org/10.2174/138945009789753192.
  203. Ritz E, Orth SR. Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med. 1999;341(15):1127-1133. https://doi.org/10.1056/NEJM199910073411506.
  204. Roma-Rodrigues C, Fernandes AR, Baptista PV. Exosome in tumour microenvironment: overview of the crosstalk between normal and cancer cells. Biomed Res Int. 2014;2014:179486. https://doi.org/10.1155/2014/179486.
  205. Royo F, Diwan I, Tackett MR, et al. Comparative miRNA analysis of urine extracellular vesicles isolated through five different methods. Cancers (Basel). 2016;8(12):112. https://doi.org/10.3390/cancers8120112.
  206. Royo F, Zuñiga-Garcia P, Torrano V, et al. Transcriptomic profiling of urine extracellular vesicles reveals alterations of CDH3 in prostate cancer. Oncotarget. 2016;7(6):6835-6846. https://doi.org/10.18632/oncotarget.6899.
  207. Sabolic I, Valenti G, Verbabatz JM, et al. Localization of the CHIP28 water channel in rat kidney. Am J Physiol. 1992;263: C1225-C1233. https://doi.org/10.1152/ajpcell.1992.263.6.C1225.
  208. Sabaratnam R, Geertsen L, Skjodt K, et al. In human nephrectomy specimens, the kidney level of tubular transport proteins does not correlate with their abundance in urinary extracellular vesicles. Am J Physiol Renal Physiol. 2019;317(3): F560-F571. https://doi.org/10.1152/ajprenal.00242.2019.
  209. Sagrinati C, Netti GS, Mazzinghi B, et al. Isolation and characterization of multipotent progenitor cells from the Bowman’s capsule of adult human kidneys. J Am Soc Nephrol. 2006;17(9):2443-2456. https://doi.org/10. 1681/ASN.2006010089.
  210. Salamone M, Carfì Pavia F, Ghersi G. Proteolytic enzymes clustered in specialized plasma-membrane domains drive endothelial cells’ migration. PLoS ONE. 2016;11(5):e0154709. https://doi.org/10.1371/journal.pone.0154709.
  211. Salih M, Zietse R, Hoorn EJ. Urinary extracellular vesicles and the kidney: biomarkers and beyond. Am J Physiol Renal Physiol. 2014;306(11):F1251-F1259. https://doi.org/10.1152/ajprenal.00128.2014.
  212. Sanchez CA, Andahur EI, Valenzuela R, et al. Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche. Oncotarget. 2016;7(4):3993-4008. https://doi.org/10.18632/oncotarget.6540.
  213. Sato S, Zhu XL, Sly WS. Carbonic anhydrase isozymes IV and II in urinary membranes from carbonic anhydrase II-deficient patients. Proc Natl Acad Sci USA. 1990;87(16):6073-6076. https://doi.org/10.1073/pnas. 87.16.6073.
  214. Shtam TA, Kovalev RA, Varfolomeeva EY, et al. Exosomes are natural carriers of exogenous siRNA to human cells in vitro. Cell Commun Signal. 2013;11:88. https://doi.org/10.1186/1478-811X-11-88.
  215. Sidhu SS, Mengistab AT, Tauscher AN, et al. The microvesicle as a vehicle for EMMPRIN in tumor-stromal interactions. Oncogene. 2004;23(4):956-963. https://doi.org/10.1038/sj.onc.1207070.
  216. Singaravelu K, Padanilam BJ. In vitro differentiation of MSC into cells with a renal tubular epithelial-like phenotype. Ren Fail. 2009;31(6):492-502. https://doi.org/10.1080/08860220902928981.
  217. Skog J, Wurdinger T, van Rijn S, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008;10(12):1470-1476. https://doi.org/10.1038/ncb1800.
  218. Smalley DM, Sheman NE, Nelson K, Theodorescu D. Isolation and identification of potential urinary microparticle biomarkers of bladder cancer. J Proteome Res. 2008;7(5):2088-2096. https://doi.org/10.1021/pr700775x.
  219. Souza AC, Yuen PS, Star RA. Microparticles: markers and mediators of sepsis-induced microvascular dysfunction, immunosuppression, and AKI. Kidney Int. 2015;87(6): 1100-1108. https://doi.org/10.1038/ki.2015.26.
  220. Stаhl AL, Arvidsson I, Johansson KE, et al. A novel mechanism of bacterial toxin transfer within host blood cell-derived microvesicles. PLoS Pathog. 2015;11(2):e1004619. https://doi.org/10.1371/journal.ppat.1004619.
  221. Street JM, Birkhoff W, Menzies RI, et al. Exosomal transmission of functional aquaporin 2 in kidney cortical collecting duct cells. J Physiol. 2011;589(24):6119-6127. https://doi.org/10.1113/jphysiol.2011.220277.
  222. Svenningsen P, Sabaratnam R, Jensen BL. Urinary extracellular vesicles: origin, role as intercellular messengers and biomarkers; efficient sorting and potencial treatment options. Acta Physiol (Oxf). 2020;228(1):e13346. https://doi.org/10.1111/apha.13345.
  223. Tangtanatakul P, Klinchanhom S, Sodsai P, et al. Down-regulation of let-7a and miR-21 in urine exosomes from lupus nephritis patients during disease flare. Asian Pac J Allergy Immunol. 2019;37(4):189-197. https://doi.org/10.12932/AP-130318-0280.
  224. Taraboletti G, D’Ascenzo S, Borsotti P, et al. Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells. Am J Pathol. 2002;160(2):673-680. https://doi.org/10.1016/S0002-9440(10)64887-0.
  225. Tian J, Casella G, Zhang Y, et al. Potential roles of extracellular vesicles in the phatophysiology, diagnosis, and treatment of autoimmune diseases. Int J Biol Sci. 2020;16(4):620-632. https://doi.org/10.7150/ijbs. 39629.
  226. Trajkovic K, Hsu C, Chiantia S, et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science. 2008;319(5867):1244-1247. https://doi.org/10.1126/science.1153124.
  227. Trams EG, Lauter CJ, Salem NJ, Heine U. Exfoliation of membrane ecto-enzymes in the form of micro-vesicles. Biochim Biophys Acta. 1981;645(1):63-70. https://doi.org/10.1016/0005-2736(81)90512-5.
  228. Trnka P, Ivanova L, Hiatt MJ, Matsell DG. Urinary biomarkers in obstructive nephropathy. Clin J Am Soc Nephrol. 2012;7(10):1567-1575. https://doi.org/10.2215/CJN. 09640911.
  229. Turco AE, Lam W, Rule AD, et al. Specific renal parenchymal-derived urinary extracellular vesicles identify age-associated structural changes in living donor kidneys. J Extracell Vesicles. 2016;5:29642. https://doi.org/10.3402/jev.v5.29642.
  230. Turturici G, Tinnirello R, Sconzo G, Geraci F. Extracellular membrane vesicles as a mechanism of cell-to-cell communication: advantages and disadvantages. Am J Physiol Cell Physiol. 2014;306(7):C621-C633. https://doi.org/10.1152/ajpcell.00228.2013.
  231. Ulivieri C, Baldari CT. Regulation of T cell activation and differentiation by extracellular vesicles and their pathogenic role in systemic lupus erythematosus and multiple sclerosis. Molecules. 2017;22(2):E225. https://doi.org/10.3390/molecules22020225.
  232. Valenti R, Huber V, Filipazzi P, et al. Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes. Cancer Res. 2006;66(18):9290-9298. https://doi.org/10.1158/0008-5472.CAN-06-1819.
  233. Van Balkom BW, de Jong OG, Smits M, et al. Endothelial cells require miR-214 to secrete exosomes that suppress senescence and induce angiogenesis in human and mouse endothelial cells. Blood. 2013;121(19):3997-4006, S1-S15. https://doi.org/10.1182/blood-2013-02-478925.
  234. Van Balkom BW, Pisitkun T, Verhaar MC, Knepper MA. Exosomes and the kidney: prospects for diagnosis and therapy of renal diseases. Kidney Int. 2011;80(11):113845. https://doi.org/10.1038/ki.2011.292.
  235. Villarroya-Beltri C, Baixauli F, Gutiérrez-Vázquez C, et al. Sorting it out: regulation of exosome loading. Semin Cancer Biol. 2014;28:3-13. https://doi.org/10.1016/j.semcancer.2014.04.009.
  236. Viñas JL, Burger D, Zimpelmann J, et al. Transfer of microRNA-486-5p from human endothelial colony forming cell-derived exosomes reduces ischemic kidney injury. Kidney Int. 2016;90(6):1238-1250. https://doi.org/10.1016/j.kint.2016.07.015.
  237. Wang B, Yao K, Huuskes BM, et al. Mesenchymal stem cells deliver exogenous microRNA-let7c via exosomes to attenuate renal fibrosis. Mol Ther. 2016;24(7):1290-1301. https://doi.org/10.1038/mt.2016.90.
  238. Wang L, Skotland T, Berge V, et al. Exosomal proteins as prostate cancer biomarkers in urine: from mass spectrometry discovery to immunoassay-based validation. Eur J Pharm Sci. 2017;98:80-85. https://doi.org/ 10.1016/j.ejps.2016.09.023.
  239. Wang Y, Lu X, He J, Zhao W. Influence of erythropoietin on microvesicles derived from mesenchymal stem cells protecting renal function of chronic kidney disease. Stem Cell Res Ther. 2015;6(1):100. https://doi.org/10.1186/s13287-015-0095-0.
  240. Webber J, Steadman R, Mason MD, et al. Cancer exosomes trigger fibroblast to myofibroblast differentiation. Cancer Res. 2010;70(23):9621-9630. https://doi.org/10.1158/0008-5472.CAN-10-1722.
  241. Welton JL, Brennan P, Gurney M, et al. Proteomics analysis of vesicles isolated from plasma and urine of prostate cancer patients using a multiplex, aptamer-based protein array. J Extracell Vesicles. 2016;5:31209. https://doi.org/10.3402/jev.v5.31209.
  242. Wendler F, Favicchio R, Simon T, et al. Extracellular vesicles swarm the cancer microenvironment: from tumor-stroma communication to drug intervention. Oncogene. 2017; 36(7):877-884. https://doi.org/10.1038/onc.2016.253.
  243. Wieckowski EU, Visus C, Szajnik M, et al. Tumor-derived microvesicles promote regulatory T cell expansion and induce apoptosis in tumor-reactive activated CD8+ T lymphocytes. J Immunol. 2009;183(6):3720-3730. https://doi.org/10.4049/jimmunol.0900970.
  244. Wright PA, Packer RK, Garcia-Perez A, Knepper MA. Time course of renal glutamate dehydrogenase induction during NH4Cl loading in rats. Am J Physiol. 1992; 262(6):F999-F1006. https://doi.org/10.1152/ajprenal. 1992.262.6.F999.
  245. Yáñez-Mó M, Siljander PR, Andreu Z, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015;4:27066. https://doi.org/10.3402/jev.v4.27066.
  246. Yang C, Xiong W, Qiu Q, et al. Role of receptor-mediated endocytosis in the antiangiogenic effects of human T lymphoblastic cell-derived microparticles. Am J Physiol Regul Integr Comp Physiol. 2012;302(8):R941-R949. https://doi.org/10.1152/ajpregu.00527.2011.
  247. Yang L, Wu XH, Wang D, et al. Bladder cancer cell-derived exosomes inhibit tumour cell apoptosis and induce cell proliferation in vitro. Mol Med Rep. 2013;8(4):1272-1278. https://doi.org/10.3892/mmr.2013.1634.
  248. Yoder BK, Hou X, Guay-Woodford LM. The polycystic kidney disease proteins, polycystin 1, polycystin 2, polaris, and co-localized in renal cilia. J Am Soc Nephrol. 2002;13(10):2508-2516. https://doi.org/10.1097/01.ASN.0000029587.47950.25.
  249. Yu X, Harris SL, Levine AJ. The regulation of exosome secretion: a novel function of the p53 protein. Cancer Res. 2006;66(9):4795-4801. https://doi.org/10.1158/0008-5472.CAN-05-4579.
  250. Yuan A, Farber EL, Rapoport AL, et al. Transfer of microRNAs by embryonic stem cell microvesicles. PLoS ONE. 2009;4(3): e4722. https://doi.org/10.1371/journal.pone.0004722.
  251. Zafrani L, Gerotziafas G, Byrnes C, et al. Calpastatin controls polymicrobial sepsis by limiting procoagulant microparticle release. Am J. Resp Crit Care Med. 2012;185(7):744-755. https://doi.org/10.1164/rccm. 201109-1686OC.
  252. Zhang W, Zou X, Zhang H, et al. Extracellular vesicles in diagnosis and kidney diseases. Am J Physiol Renal Physiol. 2016;311(5):F844-F851. https://doi.org/10.1152/ajprenal00429.2016.
  253. Zhao Y, Chen K, Li H, Wu H. Effect of pH on the isolation of urinary exosome. Int Urol Nephrol. 2017;49(1):165-169. https://doi.org/10.1007/s11255-016-1408-7.
  254. Zhou H, Kajiyama H, Tsuji T, et al. Urinary exosomal Wilms’ tumor-1 as a potential biomarker for podocyte injury. Am J Physiol Renal Physiol. 2013;305(4): F553-F559. https://doi.org/10.1152/ajprenal.00056.2013.
  255. Zhou H, Pisitkun T, Aponte A, et al. Exosomal Fetuin-A identified by proteomics: a novel urinary biomarker for detecting acute kidney injury. Kidney Int. 2006b;70(10): 1847-1857. https://doi.org/10.1038/sj.ki.5001874.
  256. Zhou H, Yuen PS, Pisitkun T, et al. Collection, storage, preservation, and normalization of human urinary exosomes for biomarker discovery. Kidney Int. 2016a;69(8): 1471-1476. https://doi.org/10.1038/sj.ki.5000273.
  257. Zomer A, van Rheenen J. Implications of extra-cellular vesicle transfer on cellular heterogeneity in cancer: what are the potential clinical ramifications? Cancer Res. 2016;76(2):2071-2075. https://doi.org/10.1158/0008-5472.CAN-15-2804.

Copyright (c) 2020 Vashchenko V.I., Shabanov P.D.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
 


Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».